HomeCompareGRNA vs PEP

GRNA vs PEP: Dividend Comparison 2026

GRNA yields 667.78% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GRNA wins by $616486.63M in total portfolio value
10 years
GRNA
GRNA
● Live price
667.78%
Share price
$0.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$616486.77M
Annual income
$476,205,667,861.38
Full GRNA calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — GRNA vs PEP

📍 GRNA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGRNAPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GRNA + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GRNA pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GRNA
Annual income on $10K today (after 15% tax)
$56,761.27/yr
After 10yr DRIP, annual income (after tax)
$404,774,817,682.17/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, GRNA beats the other by $404,774,765,087.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GRNA + PEP for your $10,000?

GRNA: 50%PEP: 50%
100% PEP50/50100% GRNA
Portfolio after 10yr
$308243.46M
Annual income
$238,102,864,868.53/yr
Blended yield
77.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

GRNA
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Price Target
$11.00
+3572.8% upside vs current
Range: $4.00 — $18.00
Altman Z
-9.5
Piotroski
2/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GRNA buys
0
PEP buys
0
No recent congressional trades found for GRNA or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGRNAPEP
Forward yield667.78%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$616486.77M$141.9K
Annual income after 10y$476,205,667,861.38$61,875.67
Total dividends collected$605026.56M$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold
Analyst price target$11.00$172.43

Year-by-year: GRNA vs PEP ($10,000, DRIP)

YearGRNA PortfolioGRNA Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$77,478$66,777.96$10,849$509.42+$66.6KGRNA
2$566,436$483,534.63$11,969$750.47+$554.5KGRNA
3$3,909,908$3,303,820.95$13,500$1,124.14+$3.90MGRNA
4$25,496,784$21,313,183.41$15,680$1,721.66+$25.48MGRNA
5$157,173,879$129,892,319.14$18,929$2,715.34+$157.15MGRNA
6$916,508,625$748,332,575.36$24,023$4,450.80+$916.48MGRNA
7$5,058,850,510$4,078,186,281.00$32,510$7,669.92+$5058.82MGRNA
8$26,450,685,234$21,037,715,188.18$47,709$14,093.60+$26450.64MGRNA
9$131,103,833,389$102,801,600,188.27$77,415$28,083.48+$131103.76MGRNA
10$616,486,769,587$476,205,667,861.38$141,922$61,875.67+$616486.63MGRNA

GRNA vs PEP: Complete Analysis 2026

GRNAStock

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.

Full GRNA Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this GRNA vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GRNA vs SCHDGRNA vs JEPIGRNA vs OGRNA vs KOGRNA vs MAINGRNA vs MOGRNA vs PMGRNA vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.